160 related articles for article (PubMed ID: 37537541)
1. Involved site radiation therapy in stage I-III nasopharyngeal carcinoma with limited lymph node burden (ISRT-NPC) or elective region irradiation: a study protocol for a multicenter non-inferiority randomized controlled phase III clinical trial.
Liu Y; Han Y; Liu F; Hu D; Chen Z; Wang P; Li J; Qin J; Jin F; Li Y; Wang J; Yi J
BMC Cancer; 2023 Aug; 23(1):724. PubMed ID: 37537541
[TBL] [Abstract][Full Text] [Related]
2. POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial.
Zhao XR; Fang H; Tang Y; Hu ZH; Jing H; Liang L; Yan XN; Song YW; Jin J; Liu YP; Chen B; Tang Y; Qi SN; Li N; Lu NN; Men K; Hu C; Zhang YH; Li YX; Wang SL
BMC Cancer; 2021 Nov; 21(1):1185. PubMed ID: 34742270
[TBL] [Abstract][Full Text] [Related]
3. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
[TBL] [Abstract][Full Text] [Related]
4. The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels.
Ou X; Miao Y; Wang X; Ding J; He X; Hu C
Radiat Oncol; 2017 Aug; 12(1):137. PubMed ID: 28821277
[TBL] [Abstract][Full Text] [Related]
5. Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial.
Tang LL; Huang CL; Zhang N; Jiang W; Wu YS; Huang SH; Mao YP; Liu Q; Li JB; Liang SQ; Qin GJ; Hu WH; Sun Y; Xie FY; Chen L; Zhou GQ; Ma J
Lancet Oncol; 2022 Apr; 23(4):479-490. PubMed ID: 35240053
[TBL] [Abstract][Full Text] [Related]
6. Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical Trial.
Tang LL; Guo R; Zhang N; Deng B; Chen L; Cheng ZB; Huang J; Hu WH; Huang SH; Luo WJ; Liang JH; Zheng YM; Zhang F; Mao YP; Li WF; Zhou GQ; Liu X; Chen YP; Xu C; Lin L; Liu Q; Du XJ; Zhang Y; Sun Y; Ma J
JAMA; 2022 Aug; 328(8):728-736. PubMed ID: 35997729
[TBL] [Abstract][Full Text] [Related]
7. The boundary of posterior to level V region and the theoretical feasibility of irradiation dose reduction of level Va in nasopharyngeal carcinoma.
Jiang C; Li X; Zhang L; Gong B; Gao H; Li Z; Zhang T; Wang J
Sci Rep; 2024 Jan; 14(1):2308. PubMed ID: 38280907
[TBL] [Abstract][Full Text] [Related]
8. Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.
Lv X; Cao X; Xia WX; Liu KY; Qiang MY; Guo L; Qian CN; Cao KJ; Mo HY; Li XM; Li ZH; Han F; He YX; Liu YM; Wu SX; Bai YR; Ke LR; Qiu WZ; Liang H; Liu GY; Miao JJ; Li WZ; Lv SH; Chen X; Zhao C; Xiang YQ; Guo X
Lancet Oncol; 2021 May; 22(5):716-726. PubMed ID: 33857411
[TBL] [Abstract][Full Text] [Related]
9. Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial.
Mao YP; Wang SX; Gao TS; Zhang N; Liang XY; Xie FY; Zhang Y; Zhou GQ; Guo R; Luo WJ; Li YJ; Liang SQ; Lin L; Li WF; Liu X; Xu C; Chen YP; Lv JW; Huang SH; Liu LZ; Li JB; Tang LL; Chen L; Sun Y; Ma J
BMJ; 2023 Feb; 380():e072133. PubMed ID: 36746459
[TBL] [Abstract][Full Text] [Related]
10. [Prophylactic irradiation of cervical lymph nodes for Stage-N0 nasopharyngeal carcinoma].
Xie FY; Peng M; Hu WH; Han F; Wang X; Xu HM
Chin J Cancer; 2010 Jan; 29(1):106-10. PubMed ID: 20038321
[TBL] [Abstract][Full Text] [Related]
11. Clinical treatment considerations in the intensity-modulated radiotherapy era for parotid lymph node metastasis in patients with nasopharyngeal carcinoma.
Lin C; Lu N; Liang JL; Guo J; Gu LW; Sun R; Guo L; Yang Q
Radiother Oncol; 2023 Sep; 186():109802. PubMed ID: 37423477
[TBL] [Abstract][Full Text] [Related]
12. Enhanced control by radiotherapy of cervical lymph node metastases arising from nasopharyngeal carcinoma compared with nodal metastases from other head and neck squamous cell carcinomas.
Chow E; Payne D; Keane T; Panzarella T; Izard MA
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):149-54. PubMed ID: 9300749
[TBL] [Abstract][Full Text] [Related]
13. Evidence on Effectiveness of Upper Neck Irradiation Versus Whole Neck Irradiation as Elective Neck Irradiation in Node-Negative Nasopharyngeal Cancer: A Meta-Analysis.
Co JL; Mejia MBA; Dizon JMR
J Glob Oncol; 2018 Sep; 4():1-11. PubMed ID: 30241188
[TBL] [Abstract][Full Text] [Related]
14. Distribution of regional lymph lode metastasis in unilateral nasopharyngeal carcinoma and the suggestions for selective prophylactic irradiation with intensity-modulated radiotherapy.
Lin F; Qiu Z; Xie D; Zhou X; Wang L; Wu Z; Cheng W; Lyu S; Su Y; Tao Y
Cancer Med; 2023 Nov; 12(21):20511-20520. PubMed ID: 37881136
[TBL] [Abstract][Full Text] [Related]
15. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
Henke G; Knauer M; Ribi K; Hayoz S; Gérard MA; Ruhstaller T; Zwahlen DR; Muenst S; Ackerknecht M; Hawle H; Fitzal F; Gnant M; Mátrai Z; Ballardini B; Gyr A; Kurzeder C; Weber WP
Trials; 2018 Dec; 19(1):667. PubMed ID: 30514362
[TBL] [Abstract][Full Text] [Related]
16. [Magnetic resonance imaging analysis of regional lymph node metastasis in 1 298 cases of nasopharyngeal carcinoma].
Lv J; Wang R; Qing Y; Du Q; Zhang T
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(18):769-72. PubMed ID: 23259286
[TBL] [Abstract][Full Text] [Related]
17. Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy.
Li WF; Sun Y; Mao YP; Chen L; Chen YY; Chen M; Liu LZ; Lin AH; Li L; Ma J
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):249-56. PubMed ID: 23200171
[TBL] [Abstract][Full Text] [Related]
18. Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence.
Ho FC; Tham IW; Earnest A; Lee KM; Lu JJ
BMC Cancer; 2012 Mar; 12():98. PubMed ID: 22433671
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.
Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248
[TBL] [Abstract][Full Text] [Related]
20. Patterns of lymph node metastasis from nasopharyngeal carcinoma based on the 2013 updated consensus guidelines for neck node levels.
Wang X; Hu C; Ying H; He X; Zhu G; Kong L; Ding J
Radiother Oncol; 2015 Apr; 115(1):41-5. PubMed ID: 25748143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
